mhurhangee/ep-ind-claims huggingface dataset:
An unmanned aerial vehicle for mounting a clamp to a line comprising: a body; a first propeller attached to the body; a guide attached to the body and configured to support the clamp for mounting to the line by flying the unmanned aerial vehicle toward the line; and a propeller guard attached to the body and configured to inhibit the propeller from contacting the line and to direct the clamp to the line, characterized in that the propeller guard is below the propeller, to an exterior side of the propeller relative to the body, and above the propeller. a body; a first propeller attached to the body; a guide attached to the body and configured to support the clamp for mounting to the line by flying the unmanned aerial vehicle toward the line; and a propeller guard attached to the body and configured to inhibit the propeller from contacting the line and to direct the clamp to the line, characterized in that the propeller guard is below the propeller, to an exterior side of the propeller relative to the body, and above the propeller.
A seamless steel pipe for line pipe, wherein a chemical composition consists, by mass percent, of C: 0.03 to 0.10%, Si: 0.50% or less, Mn: 1.0 to 2.0%, P: 0.050% or less, S: 0.005% or less, Cr: 0.05 to 1.0%, Mo: 0.01 to 0.30%, Al: 0.001 to 0.10%, N: 0.01% or less, Ni: 0.04 to 2.0%, Ca: 0.0005 to 0.0050%, Cu: 0 to 2.0%, Ti: 0 to 0.05%, Nb: 0 to 0.05%, V: 0 to 0.10%, the balance: Fe and impurities, and the chemical composition satisfies the conditions of Cu + Ni: 0.10% or more, and Mo + V: 0.30% or less, wherein a metal micro-structure of the steel pipe contains 50% or more of bainite, in an area fraction; in a scale formed on the surface of the steel pipe, metal particles consisting mainly of Ni or Cu having an average circle-equivalent diameter of 0.1 to 5 μm exist, and a distance from a boundary between the base metal of the steel pipe and the scale to a region in which the metal particles do not exist is 20 μm or longer, wherein the distribution of metal particles consisting mainly of Ni or Cu is examined using a backscattered electron image and an element mapping image obtained by EPMA.
A method for decorating a surface, in order to apply a predefined image to a destination surface, comprising the steps of: a) preparing a base sheet, which contains an adhesive, b) reproducing the predefined image on the base sheet, c) applying a backing film to the image, for the subsequent retention of the correct positioning of the image, d) covering the backing film with an additional stiffening film, which is adapted to increase the rigidity of the image and/or of the backing film, the assembly composed of the base sheet, the image, the backing film and the stiffening film defining a decal; e) wetting the decal, in order to allow the transfer of the adhesive toward the image; f) applying the decal to the destination surface, by bringing the base sheet into contact with the destination surface; g) sliding away the base sheet, while keeping the image positioned on the surface; h) removing the backing film and the film. a) preparing a base sheet, which contains an adhesive, b) reproducing the predefined image on the base sheet, c) applying a backing film to the image, for the subsequent retention of the correct positioning of the image, d) covering the backing film with an additional stiffening film, which is adapted to increase the rigidity of the image and/or of the backing film, the assembly composed of the base sheet, the image, the backing film and the stiffening film defining a decal; e) wetting the decal, in order to allow the transfer of the adhesive toward the image; f) applying the decal to the destination surface, by bringing the base sheet into contact with the destination surface; g) sliding away the base sheet, while keeping the image positioned on the surface; h) removing the backing film and the film.
An antibody or an antigen-binding fragment thereof having at least one antigen-binding site comprising an immunoglobulin heavy chain variable region domain and an immunoglobulin light chain variable region domain, wherein the heavy chain variable region domain comprises CDR1, CDR2, and CDR3 sequences consisting of amino acid sequences NYGLS (SEQ ID NO:4), ENHPGSGIIYHNEKFRG (SEQ ID NO:5) and SSGTRGFAY (SEQ ID NO:6), respectively, and wherein the light chain variable region domain comprises CDR1', CDR2', and CDR3' sequences consisting of amino acid sequences RSSQSIVHSNGNTYLE (SEQ ID NO:7), KVSNRFS (SEQ ID NO:8) and FQGSHGPWT (SEQ ID NO:9), respectively, and wherein the specificity of said antibody or said antigen-binding fragment thereof for a cancer-associated structure of MUC1 is 100-fold or more as compared with that for a normal tissue-associated structure of MUC1, and wherein the normal tissue-associated structure is selected from the group consisting of Neu5Acα2→3Galβ1→3[Galβ1→4 GlcNAcβ1→6]GalNAcα-R and Neu5Acα2→3Galβ1→3[Neu5Acα2→3 Galβ1→4GlcNAcβ1→6]GalNAcα-R, the cancer-associated structure is selected from the group consisting of Neu5Acα2→3Galβ1→3GalNAcα-R, GalNAcα-R and Galβ1→3GalNAcα-R, and wherein Neu5Ac is N-acetylneuraminic acid, Gal is galactose, GlcNAc is N-acetylglucosamine, GalNAc is N-acetylgalactosamine, and R is a non-sugar part.
A transport refrigeration system comprising: an electronically governed engine; and a transport refrigeration unit including a refrigeration circuit that comprises a compressor, which is configured to be driven by the engine to pump refrigerant about the refrigeration circuit, and a controller, which is configured to set a nominal engine speed at which to drive the compressor and communicate that to an engine control unit of the system; characterised in that the engine control unit is configured to operate the engine in a droop mode of operation, in which: the engine control unit operates the engine according to a predefined torque-speed profile corresponding to the nominal engine speed; and the torque-speed profile indicates different engine speeds to be used for respective engine loads, such that the engine speed increases with decreasing engine loads from the refrigeration circuit. an electronically governed engine; and a transport refrigeration unit including a refrigeration circuit that comprises a compressor, which is configured to be driven by the engine to pump refrigerant about the refrigeration circuit, and a controller, which is configured to set a nominal engine speed at which to drive the compressor and communicate that to an engine control unit of the system; characterised in that the engine control unit is configured to operate the engine in a droop mode of operation, in which: the engine control unit operates the engine according to a predefined torque-speed profile corresponding to the nominal engine speed; and the torque-speed profile indicates different engine speeds to be used for respective engine loads, such that the engine speed increases with decreasing engine loads from the refrigeration circuit. the engine control unit operates the engine according to a predefined torque-speed profile corresponding to the nominal engine speed; and the torque-speed profile indicates different engine speeds to be used for respective engine loads, such that the engine speed increases with decreasing engine loads from the refrigeration circuit.
A device, comprising: an organic vapor jet printing (OVJP) nozzle; a heating system attached to the nozzle; a source of carrier gas and a source of organic molecules in fluid communication, via a tube, with the nozzle; and an active cooling system disposed adjacent to the nozzle and separated from the tube by an insulator, wherein the nozzle protrudes from the front of the active cooling system by zero to 10 mm; wherein, when the nozzle is disposed above a substrate toward which the organic molecules are directed by the nozzle, the active cooling system is disposed above the substrate, such that the active cooling system is configured to capture organic molecules that re-evaporate or rebound from the substrate. an organic vapor jet printing (OVJP) nozzle; a heating system attached to the nozzle; a source of carrier gas and a source of organic molecules in fluid communication, via a tube, with the nozzle; and an active cooling system disposed adjacent to the nozzle and separated from the tube by an insulator, wherein the nozzle protrudes from the front of the active cooling system by zero to 10 mm; wherein, when the nozzle is disposed above a substrate toward which the organic molecules are directed by the nozzle, the active cooling system is disposed above the substrate, such that the active cooling system is configured to capture organic molecules that re-evaporate or rebound from the substrate.
A method of analyzing a biological sample, comprising: binding a plurality of detection probes indirectly to a DNA concatemer in the biological sample, wherein a detection probe of the plurality of detection probes comprises a sequence of nucleobases on a synthetic backbone, wherein the detection probe indirectly binds to a target sequence in the DNA concatemer, and wherein the detection probe hybridizes to an intermediate probe which directly or indirectly binds to the target sequence, and detecting signals from said plurality of bound detection probes, wherein the signal generated is greater than a plurality of reference detection probes having the same sequence of nucleobases on a sugar-phosphate backbone. binding a plurality of detection probes indirectly to a DNA concatemer in the biological sample, wherein a detection probe of the plurality of detection probes comprises a sequence of nucleobases on a synthetic backbone, wherein the detection probe indirectly binds to a target sequence in the DNA concatemer, and wherein the detection probe hybridizes to an intermediate probe which directly or indirectly binds to the target sequence, and detecting signals from said plurality of bound detection probes, wherein the signal generated is greater than a plurality of reference detection probes having the same sequence of nucleobases on a sugar-phosphate backbone.
A computer-implemented method for positioning orthodontic brackets, comprising: (a) receiving an input indicating a location (106, 156) selected on an image by a health care professional to indicate a position to place an orthodontic bracket on a patient's tooth, wherein the image is rendered with respect to a viewport (104, 151) mapped onto an immersive photographic model of a patient's mouth; (b) extending a ray (108, 158) from a focal point (112, 152) of the viewport (104, 151) at a direction determined based on the input; (c) determining an intersection of the ray (108, 158) in a three-dimensional space, the intersection indicating the position to place the orthodontic bracket with respect to the immersive photographic model, such that the determining step enables placement of the orthodontic bracket at the position on the patient's tooth; and (d) superimposing a mark onto the immersive photographic model to illustrate to the health care professional the location (106, 156) selected for placement of the orthodontic bracket on the patient's tooth. (a) receiving an input indicating a location (106, 156) selected on an image by a health care professional to indicate a position to place an orthodontic bracket on a patient's tooth, wherein the image is rendered with respect to a viewport (104, 151) mapped onto an immersive photographic model of a patient's mouth; (b) extending a ray (108, 158) from a focal point (112, 152) of the viewport (104, 151) at a direction determined based on the input; (c) determining an intersection of the ray (108, 158) in a three-dimensional space, the intersection indicating the position to place the orthodontic bracket with respect to the immersive photographic model, such that the determining step enables placement of the orthodontic bracket at the position on the patient's tooth; and (d) superimposing a mark onto the immersive photographic model to illustrate to the health care professional the location (106, 156) selected for placement of the orthodontic bracket on the patient's tooth.
An oral care composition comprising a phosphate/acrylate co-polymer, an anti-bacterial agent, wherein the anti-bacterial agent is ZnO and present in an amount of 0.1 to 10 weight %, and an orally acceptable carrier, wherein the phosphate/acrylate co-polymer is a co-polymerized product of a mixture of acrylic acid, methacrylic acid, and 2-hydroxyethyl methacrylate phosphates of Formula 1 comprising acrylic acid in a molar percentage of 70-90 %; methacrylic acid in a molar percentage of 5-20 %, and a mixture of hydroxyethyl methacrylate phosphates of Formula 1 in a molar percentage of 1-10 %: wherein n is 0, 1 or 2.
A tissue sealant comprising the reaction product of: (a) a polyol having at least two groups capable of reacting with an alkoxy silane; and (b) an alkoxy silane having the formula: (R 1 R 2 R 3)-Si-CH2-Z where: (i) Z is an -OH, -SH, -NCO, or -NHR 4 group, where R 4 is hydrogen or an alkyl group; and (ii) each R1, R 2, and R 3, independently, is H, an alkoxy group, an alkyl group, a heteroalkyl group other than an alkoxy group, an aryl group, or a heteroaryl group, with the proviso that at least two of R1, R 2, and R 3 are alkoxy groups, wherein the tissue sealant is moisture-curable and biodegradable in a physiological environment. (a) a polyol having at least two groups capable of reacting with an alkoxy silane; and (b) an alkoxy silane having the formula: (R 1 R 2 R 3)-Si-CH2-Z where: (i) Z is an -OH, -SH, -NCO, or -NHR 4 group, where R 4 is hydrogen or an alkyl group; and (ii) each R1, R 2, and R 3, independently, is H, an alkoxy group, an alkyl group, a heteroalkyl group other than an alkoxy group, an aryl group, or a heteroaryl group, with the proviso that at least two of R1, R 2, and R 3 are alkoxy groups, wherein the tissue sealant is moisture-curable and biodegradable in a physiological environment. (i) Z is an -OH, -SH, -NCO, or -NHR 4 group, where R 4 is hydrogen or an alkyl group; and (ii) each R1, R 2, and R 3, independently, is H, an alkoxy group, an alkyl group, a heteroalkyl group other than an alkoxy group, an aryl group, or a heteroaryl group, with the proviso that at least two of R1, R 2, and R 3 are alkoxy groups, wherein the tissue sealant is moisture-curable and biodegradable in a physiological environment.
An optical processing device, comprising a processor, at least one first interface, at least one second interface, and at least one third interface; the first interface is used to connect to and communicate with an upper-layer device, the second interface is used to connect to and communicate with a user-side device, and the third interface is used to connect to and communicate with a third interface of another optical processing module; and the processor is configured to process, according to a first control instruction, data received from the at least one first interface and the at least one third interface, wherein the first control instruction indicates an actual data bandwidth allocated to the at least one first interface and an actual data bandwidth allocated to the at least one third interface in a downlink direction, and a sum of the actual data bandwidth allocated to the at least one first interface and the actual data bandwidth allocated to the at least one third interface is not greater than a processing capability of the optical processing module; wherein the processing capability of the optical processing module is the size of a data packet that can be processed by the optical processing module per unit of time; and wherein the processor is configured to send a part or all of the data received from the first interface and the third interface to another optical processing module through another third interface different from the interface used to receive the data. the first interface is used to connect to and communicate with an upper-layer device, the second interface is used to connect to and communicate with a user-side device, and the third interface is used to connect to and communicate with a third interface of another optical processing module; and the processor is configured to process, according to a first control instruction, data received from the at least one first interface and the at least one third interface, wherein the first control instruction indicates an actual data bandwidth allocated to the at least one first interface and an actual data bandwidth allocated to the at least one third interface in a downlink direction, and a sum of the actual data bandwidth allocated to the at least one first interface and the actual data bandwidth allocated to the at least one third interface is not greater than a processing capability of the optical processing module; wherein the processing capability of the optical processing module is the size of a data packet that can be processed by the optical processing module per unit of time; and wherein the processor is configured to send a part or all of the data received from the first interface and the third interface to another optical processing module through another third interface different from the interface used to receive the data.
A battery contact system comprising: - a body having a printed circuit board therein and having a battery compartment on one surface thereof; - a battery detachably accommodated in the battery compartment; and - at least one connection unit for transmitting battery power to the body, characterized in that each connection unit comprises an insulated elastic body protruding from the battery compartment and a flexible conductor provided within the insulated elastic body, wherein one end of the flexible conductor is exposed to an upper surface of the insulated elastic body for contacting with a battery terminal, and another end of the flexible conductor contacts the printed circuit board. - a body having a printed circuit board therein and having a battery compartment on one surface thereof; - a battery detachably accommodated in the battery compartment; and - at least one connection unit for transmitting battery power to the body, characterized in that each connection unit comprises an insulated elastic body protruding from the battery compartment and a flexible conductor provided within the insulated elastic body, wherein one end of the flexible conductor is exposed to an upper surface of the insulated elastic body for contacting with a battery terminal, and another end of the flexible conductor contacts the printed circuit board.
A use of a filmic facestock material for polymeric packaging comprising: a pressure sensitive adhesive composition comprising a monomer mixture, wherein the monomer mixture comprises (a) at least one monomer which may undergo free radical polymerization and whose homopolymer has a glass transition temperature of less than or equal to 10°C comprising at least one (meth)acrylic acid ester, selected from the group consisting of benzyl acrylate, n-butyl acrylate, sec-butyl acrylate, cyanoethyl acrylate, iso-decyl acrylate, n-decyl acrylate, dodecyl acrylate, dodecyl methacrylate, 2-ethoxyethyl acrylate, ethyl acrylate, 2-ethylhexyl acrylate, 2-ethylhexyl methacrylate, n-hexyl acrylate, hexyl methacrylate, isobutyl acrylate, isopropyl acrylate, 2-methoxyethyl acrylate, methyl acrylate, octadecyl methacrylate, octyl methacrylate, 2-phenylethyl acrylate, n-propyl acrylate, and 2,2,2-trifluoroethyl acrylate, and combinations thereof, (b) at least one mono-olefinically unsaturated monomer having aldehyde or ketone functionality, and (c) an effective amount of at least one polyhydrazide crosslinker having hydrazine functionality; wherein the pressure sensitive adhesive composition exhibits a peel adhesion value of between 70N/m (0.4 lbs/in) and 700N/m (4 lbs/in) measured according ASTM Designation D3330 Standard Test Method for Peel Adhesion of Pressure-Sensitive Tape; to achieve during recycling a percent film remaining on the polymeric packaging after a sink-float testing of 0% to 8% tested as described in the description. (b) at least one mono-olefinically unsaturated monomer having aldehyde or ketone functionality, and (c) an effective amount of at least one polyhydrazide crosslinker having hydrazine functionality;
A method for chromogenic detection of two target molecules in a single tissue sample, comprising: contacting the tissue sample with a first specific binding moiety that specifically binds a first target molecule; detecting the first target molecule in the tissue sample by depositing an insoluble, electron-rich aromatic chromogen product,where chromogenically depositing comprises reacting 3,3'-Diaminobenzidine with a catalyst to directly or indirectly form the insoluble, electron-rich aromatic chromogen product; contacting the tissue sample with a second, hapten-labeled specific binding moiety that specifically binds a second target molecule, where a hapten of the second, hapten-labeled specific binding moiety is dinitrophenol; treating the tissue sample with a solution comprising a soluble, electron-rich aromatic compound comprising Naphthol phosphate prior to or concomitantly with contacting the second, dinitrophenol -labeled specific binding moiety with the tissue sample; and, detecting the second target molecule by depositing a second, insoluble chromogen product that is distinguishable from the insoluble, electron-rich aromatic compound deposited to detect the first target molecule, where treating the tissue sample with the solution containing the soluble, electron-rich aromatic compound reduces background due to non-specific binding of the dinitrophenol -labeled specific binding moiety to the insoluble electron rich compound deposited near the first target molecule. contacting the tissue sample with a first specific binding moiety that specifically binds a first target molecule; detecting the first target molecule in the tissue sample by depositing an insoluble, electron-rich aromatic chromogen product,where chromogenically depositing comprises reacting 3,3'-Diaminobenzidine with a catalyst to directly or indirectly form the insoluble, electron-rich aromatic chromogen product; contacting the tissue sample with a second, hapten-labeled specific binding moiety that specifically binds a second target molecule, where a hapten of the second, hapten-labeled specific binding moiety is dinitrophenol; treating the tissue sample with a solution comprising a soluble, electron-rich aromatic compound comprising Naphthol phosphate prior to or concomitantly with contacting the second, dinitrophenol -labeled specific binding moiety with the tissue sample; and, detecting the second target molecule by depositing a second, insoluble chromogen product that is distinguishable from the insoluble, electron-rich aromatic compound deposited to detect the first target molecule, where treating the tissue sample with the solution containing the soluble, electron-rich aromatic compound reduces background due to non-specific binding of the dinitrophenol -labeled specific binding moiety to the insoluble electron rich compound deposited near the first target molecule.